ABSTRACT
The FDA-CDC Antimicrobial Resistance Isolate Bank was created in July 2015 as a publicly available resource to combat antimicrobial resistance. It is a curated repository of bacterial isolates with an assortment of clinically important resistance mechanisms that have been phenotypically and genotypically characterized. In the first 2 years of operation, the bank offered 14 panels comprising 496 unique isolates and had filled 486 orders from 394 institutions throughout the United States. New panels are being added.
Subject(s)
Bacteria/isolation & purification , Biological Specimen Banks , Drug Resistance, Microbial , Fungi/isolation & purification , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Bacteria/genetics , Biological Specimen Banks/organization & administration , Biological Specimen Banks/standards , Centers for Disease Control and Prevention, U.S. , Communicable Diseases/diagnosis , Communicable Diseases/microbiology , Fungi/drug effects , Fungi/genetics , Humans , United States , United States Food and Drug AdministrationABSTRACT
We report the draft genome sequences of Streptococcus bovis strain ATCC 33317 (CVM42251) isolated from cow dung and strain JB1 (CVM42252) isolated from a cow rumen in 1977. The strains were sequenced using the Genome Sequencer FLX 454 system. The genome sizes are approximately 2 Mb and 2.2 Mb, respectively.
ABSTRACT
We report the draft genomes of Salmonella enterica subsp. enterica serovar Cubana strain CVM42234, isolated from chick feed in 2012, and S. Cubana strain 76814, isolated from swine in 2004. The genome sizes are 4,975,046 and 4,936,251 bp, respectively.